Drug & intervention
codeine phosphate 20 MG / guaifenesin 400 MG / pseudoephedrine hydrochloride 20 MG [Ambifed-G CD]
RxCUI 996711
What this record represents
SBDC · RxNormThis is an RxNorm SBDC drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
Ambifed-G CDBN · CureCurrent ID 297828
codeine / guaifenesin / pseudoephedrine Oral Tablet [Ambifed-G CD]SBDF · CureCurrent ID 297829
codeine phosphate 10 MG / guaifenesin 400 MG / pseudoephedrine hydrochloride 20 MG [Ambifed-G CD]SBDC · CureCurrent ID 312999
codeine phosphate 10 MG / guaifenesin 400 MG / pseudoephedrine hydrochloride 20 MG Oral Tablet [Ambifed-G CD]SBD · CureCurrent ID 313000
codeine phosphate 20 MG / guaifenesin 400 MG / pseudoephedrine hydrochloride 20 MG Oral Tablet [Ambifed-G CD]SBD · CureCurrent ID 307589
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.